• Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer
Researchers with UC San Diego Health identify a potential new treatment for uncontrolled high blood pressure.
Mount Sinai-led research can transform how hospitals triage, risk-stratify, and counsel patients to save lives
Mount Sinai-led research can transform how hospitals triage, risk-stratify, and counsel patients to save lives
A new multi-center study co-led by scientists from UCLA Health has uncovered critical genetic insights into a group of rare disorders affecting intestinal epithelial cell function, paving the way for targeted therapies that could significantly improve patient outcomes.
A new study from the Uniformed Services University (USU), "Rethinking Shadowing for Aspiring Physicians", published in the New England Journal of Medicine, challenges the traditional emphasis on physician shadowing as a key criterion for medical school admission, highlighting its financial and accessibility barriers for many aspiring doctors.
The FDA approval was based on results from the CABINET study, a phase 3 pivotal trial evaluating cabozantinib compared with placebo in two groups of patients with previously treated NETs: advanced pancreatic NETs and advanced extra-pancreatic NETs. The study was led by Jennifer Chan, MD, MPH, clinical director of the gastrointestinal cancer center and director of the program in carcinoid and neuroendocrine tumors at Dana-Farber Cancer Institute.
Two new drugs offer chance for patients who don’t respond to existing treatments to break through the “therapeutic ceiling” for ulcerative colitis.
A modified bone marrow transplant procedure for sickle cell disease (SCD) co-developed at Vanderbilt University Medical Center, Johns Hopkins University School of Medicine, and the University of California, San Francisco, can cure the disease, a new study has found.
An artificial intelligence (AI) program can identify chronic liver disease from videos taken during a common heart test known as an echocardiogram, Cedars-Sinai investigators report.
A Penn Medicine pilot study shows it’s possible to use digital technology to safely reduce the amount of time some patients with cancer spend receiving care.
Combining bupropion medication and a behavioral counseling program dramatically increased quit rates among people living with HIV who smoked.
People living with tricuspid valve disease are gaining more treatment options, driven by research from Cedars-Sinai investigators and collaborators at other leading medical institutions.
Set to enter hospice care, a patient with idiopathic multicentric Castleman’s disease is now in remission after treatment with a medication identified by an AI-guided analysis
Shoulder symptoms led to an average of 9.6 million physician visits in 2015 and 2016 in the United States.The most common cause of those shoulder symptoms?Rotator-cuff disorders.Tears of the rotator cuff can result from a substantial traumatic injury or can occur slowly over time.
• Study finds three new safe and effective drug regimens to fight multidrug-resistant TB • The treatments, which include recently discovered TB drugs, give new options for shorter, personalized treatment and are cleared for use for more people than ever
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
The University of Chicago Medicine has launched a Phase 2 clinical trial to study how CAR T-cell therapy could be used to treat three autoimmune diseases.
Women who were cared for by the MedStar Health D.C. Safe Babies Safe Moms program (SBSM) have better outcomes in pregnancy, delivery, and postpartum, according to a study published today in NEJM Catalyst Innovations in Care Delivery.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right